Evidence method
Level · gp.fundamentals.capex_revenue_ratio
6.38% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
UGI · Mar 31, 2026
UGI CORP /PA/. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000884614-26-000022General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
24.91% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
1.25% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
11.97% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.operating_margin
28.43% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History7 statesHistory building
Period transition
What moved in the state?
- Previous
- 10.70%
- Current
- 6.38%
- Delta
- -4.33%
- Previous
- 3.20%
- Current
- 24.91%
- Delta
- 21.71%
- Previous
- 3.87%
- Current
- 1.25%
- Delta
- -2.62%
- Previous
- 18.98%
- Current
- 11.97%
- Delta
- -7.02%
- Previous
- 21.99%
- Current
- 28.43%
- Delta
- 6.45%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Has State · UGI CORP /PA/ →Transitioned To · UGI Fundamental State →Transitioned To · UGI CAPEX_INTENSITY_DECREASED →Transitioned To · UGI CASH_GENERATION_INCREASED →Transitioned To · UGI GROWTH_DECREASED →Transitioned To · UGI INVENTORY_PRESSURE_DECREASED →Transitioned To · UGI PROFITABILITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.